GASTROINTESTINAL CANCER
Clinical trials for GASTROINTESTINAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL CANCER trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nanoparticles may help radiation zap stubborn brain tumors
Disease control OngoingThis study tests whether adding AGuIX gadolinium-based nanoparticles to standard stereotactic radiation can better control brain metastases that are at high risk of coming back after radiation alone. About 134 adults with brain tumors from cancers like melanoma, lung, breast, or …
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 05:57 UTC
-
New drug targets tough GI cancers in mid-stage trial
Disease control OngoingThis study tests a new medicine called raludotatug deruxtecan in people with advanced gastrointestinal cancers, including pancreatic, bile duct, colorectal, stomach, and gastroesophageal junction cancers. The drug works like a guided missile, attaching to a protein on cancer cell…
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 05:57 UTC
-
New hope for cancer patients: drug may prevent chemo delays from low platelets
Disease control OngoingThis study tests whether the drug avatrombopag can safely raise low platelet counts caused by chemotherapy in people with gastrointestinal cancers. About 60 adults will receive either avatrombopag or a placebo. The goal is to see if the drug helps patients keep their platelet cou…
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Gut bacteria boost after cancer surgery: postbiotics tested in new trial
Disease control ENROLLING_BY_INVITATIONThis study tests whether taking postbiotic supplements after colon cancer surgery can help restore the natural balance of gut bacteria, which is often disrupted by the procedure. Researchers will compare changes in gut bacteria diversity between 30 adults who receive the suppleme…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: University of South Florida • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
Engineered immune cells and vaccine take on Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a treatment for adults with metastatic solid tumors (like colorectal, lung, or breast cancer) that have a specific genetic change called KRAS. Doctors take a person's own white blood cells, modify them in a lab to better recognize and attack cancer ce…
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New imaging agent spots hidden cancers
Diagnosis OngoingThis pilot study tests a special PET scan that uses a radioactive tracer (64Cu-M5A) to find cancers that produce a protein called CEA. The goal is to see if this scan can detect tumors that standard methods might miss. About 20 adults with breast, colon, lung, or other CEA-positi…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 26, 2026 05:45 UTC
-
Magic mushroom compound tested to ease cancer anxiety
Symptom relief OngoingThis early-stage study tests whether a single dose of psilocybin, the active ingredient in magic mushrooms, can reduce depression and anxiety in people with advanced pancreatic, biliary, or other gastrointestinal cancers. 24 participants and their family members are involved. The…
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated May 26, 2026 05:48 UTC
-
Smartphone ChatBot could cut cancer Patients' emergency trips
Symptom relief OngoingThis study tests whether a chatbot combined with continuous activity monitoring via a smartphone can help detect and manage symptoms early in people undergoing chemotherapy and radiation for lung, gastrointestinal, or head and neck cancers. The goal is to reduce unplanned hospita…
Matched conditions: GASTROINTESTINAL CANCER
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated May 18, 2026 12:10 UTC
-
Cancer Patients' weekly Check-Ins could transform treatment experience
Knowledge-focused OngoingThis study gathers information from 100 adults with breast, lung, gastrointestinal cancer, or multiple myeloma. Participants complete weekly online surveys about their symptoms and treatment experience for at least 12 weeks. The goal is to understand how symptoms change over time…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: Carevive Systems, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 05:59 UTC
-
New study reveals cancer treatment gaps for american indians
Knowledge-focused OngoingThis study looks back at medical records of 72 American Indian patients treated with immunotherapy for different cancers. Researchers want to see how long these patients lived without their cancer getting worse, their overall survival, and side effects compared to White patients.…
Matched conditions: GASTROINTESTINAL CANCER
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated May 26, 2026 05:49 UTC
-
Cell collection study lays groundwork for future cancer therapies
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects white blood cells and tumor samples from up to 7,000 cancer patients and healthy volunteers. The cells are used in the lab to grow large numbers of immune cells that may one day be given back to patients as experimental treatments. Participants do not receive …
Matched conditions: GASTROINTESTINAL CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 05:47 UTC
-
Blood test may catch cancer return sooner, boosting cure chances
Knowledge-focused OngoingThis study compares two ways of monitoring colorectal cancer patients after surgery: standard CT scans versus a new approach that also uses a blood test (ctDNA) to find cancer DNA. The goal is to see if the blood test helps detect cancer recurrence earlier and allows more patient…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: Claus Lindbjerg Andersen • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Cancer tissue bank study seeks 1,200 volunteers to unlock new treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects leftover tissue and blood samples from people with known or suspected cancer who are already scheduled for surgery or biopsy. Researchers will compare cancerous and normal tissues to find differences that could lead to new treatments. No extra procedures are d…
Matched conditions: GASTROINTESTINAL CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
Sleep study in GI cancer patients pulled before it began
Knowledge-focused TerminatedThis study planned to track sleep quality in adults with gastrointestinal cancers before and after surgery using a simple questionnaire. It was withdrawn before any participants were enrolled, so no results are available. The goal was simply to learn more about sleep patterns, no…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Can a nurse training program improve care for cancer patients and their families?
Knowledge-focused OngoingThis study looks at whether a new training program for nurses, called PACT, helps them better support families of patients with advanced gastrointestinal cancer. The program teaches nurses how to involve family caregivers in care and connect them with resources. Researchers will …
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
Gene test aims to cut chemo side effects
Knowledge-focused TerminatedThis study looks at whether giving doctors information about a patient's genes can help them personalize chemotherapy doses and reduce severe side effects. About 860 adults with certain cancers (like breast, gastrointestinal, or head and neck) will be randomly assigned to have th…
Matched conditions: GASTROINTESTINAL CANCER
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC